United States - English - NLM (National Library of Medicine)

naimco, inc. dba richmar, inc. - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987) - lidocaine 25.3 mg in 0.24 mg - use for the temporary relief of pain.

United States - English - NLM (National Library of Medicine)

h2ocean, llc - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987) - lidocaine 4 g in 100 ml - pain reliever for the temporary relief of pain and/or itching associated with minor skin irritations

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

kievmedpreparat pjsc - captopril - tablets - 25mg

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - amoxicillin (unii: 804826j2hu) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium tablets, usp and other antibacterial drugs, amoxicillin and clavulanate potassium tablets, usp should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. amoxicillin and clavulanate potassium tablets, usp is a combination penicillin-class antibacterial and beta-lactamase inhibitor indicated in the treatment of infections due to susceptible isolates of the designated bacteria in the conditions listed below*: caused by beta-lactamase-producing isolates of haemophilus influenzae and moraxella catarrhalis . caused by beta-lactamase-producing isolates of h. influenza  and m. c

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - terlipressin -

United States - English - NLM (National Library of Medicine)

chattem, inc. - pyrithione zinc (unii: r953o2rhz5) (pyrithione zinc - unii:r953o2rhz5) - pyrithione zinc 0.01 g in 1 ml - antidandruff fights and helps prevent recurrence of flaking and itching due to dandruff

United States - English - NLM (National Library of Medicine)

sato pharmaceutical co., ltd. - tolnaftate (unii: 06kb629tkv) (tolnaftate - unii:06kb629tkv) - tolnaftate 1 g in 100 g - purpose     antifungal uses ■for effective treatment of most athlete’s foot, jock itch, and ringworm           ■prevents the recurrence of most athlete’s foot with daily use

United States - English - NLM (National Library of Medicine)

sato pharmaceutical co., ltd. - tolnaftate (unii: 06kb629tkv) (tolnaftate - unii:06kb629tkv) - tolnaftate 1 g in 100 ml - purpose     antifungal uses ■ for effective treatment of most athlete’s foot, jock itch, and ringworm ■prevents the recurrence of most athlete’s foot with daily use do not use ■on children under 2 years of age unless directed by a doctor

United States - English - NLM (National Library of Medicine)

carver korea co ltd - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine 0.12 mg in 30 ml

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - terlipressin, quantity: 0.85 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium acetate trihydrate; acetic acid - glypressin is indicated for the:,?treatment of bleeding oesophageal varices (bov);,?treatment of patients with type 1 hepatorenal syndrome (hrs) who are actively beingconsidered for liver transplant.